Gait variability in Parkinson's disease: influence of walking speed and dopaminergic treatment.

Objectives: To study the effects of levodopa and walking speed on gait variability in individuals with Parkinson's disease (PD).

Methods: Thirty-three individuals with PD were studied. Their mean age was 70.